Cargando…

Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity

The small-molecule inhibitor of p53-Mdm2 interaction, Nutlin-3, is known to be effective against cancers expressing wild-type (wt) p53. p53 mutations are rare in nasopharyngeal carcinoma (NPC), hence targeting disruption of p53-Mdm2 interaction to reactivate p53 may offer a promising therapeutic str...

Descripción completa

Detalles Bibliográficos
Autores principales:	VOON, YEE-LIN, AHMAD, MUNIRAH, WONG, POOI-FONG, HUSAINI, ROSLINA, NG, WAYNE TIONG-WENG, LEONG, CHEE-ONN, LANE, DAVID PHILIP, KHOO, ALAN SOO-BENG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564086/ https://www.ncbi.nlm.nih.gov/pubmed/26252575 http://dx.doi.org/10.3892/or.2015.4177

Ejemplares similares

Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
por: Yee-Lin, Voon, et al.
Publicado: (2018)

Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway
por: Husaini, Roslina, et al.
Publicado: (2011)

Gonadotropin-releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells
por: TENG, LOONG HUNG, et al.
Publicado: (2015)

Inhibition of nasopharyngeal carcinoma cell proliferation and synergism of cisplatin with silvestrol and episilvestrol isolated from Aglaia stellatopilosa
por: DAKER, MAELINDA, et al.
Publicado: (2016)

Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
por: Siak, Pui Yan, et al.
Publicado: (2021)

Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro
por: Husaini, Roslina, et al.
Publicado: (2017)

Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells
por: Daker, Maelinda, et al.
Publicado: (2012)

Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
por: Pua, Lesley Jia Wei, et al.
Publicado: (2022)

Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides
por: Wei, Siau Jia, et al.
Publicado: (2013)

Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells
por: DAKER, MAELINDA, et al.
Publicado: (2012)

Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
por: Aminuddin, Amnani, et al.
Publicado: (2020)

Author Correction: Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
por: Aminuddin, Amnani, et al.
Publicado: (2021)

Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2
por: Chee, Sharon Min Qi, et al.
Publicado: (2014)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023)

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition
por: Wei, Siau Jia, et al.
Publicado: (2013)

Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives
por: Su, Zhi Yi, et al.
Publicado: (2022)

Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
por: Tiong, Kai Hung, et al.
Publicado: (2013)

Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line
por: Hoe, Susan Ling Ling, et al.
Publicado: (2014)

Inhibitory effects of Cinnamomum burmannii Blume stem bark extract and trans-cinnamaldehyde on nasopharyngeal carcinoma cells; synergism with cisplatin
por: DAKER, MAELINDA, et al.
Publicado: (2013)

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
por: Ohnstad, Hege O, et al.
Publicado: (2011)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
por: Looi, Chin King, et al.
Publicado: (2021)

Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma
por: Ahmad, Munirah, et al.
Publicado: (2018)

Awakening p53 in senescent cells using nutlin-3
por: Schug, Thaddeus T.
Publicado: (2009)

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts
por: Cao, Long-Hui, et al.
Publicado: (2016)

Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3
por: Funston, Garth, et al.
Publicado: (2012)

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
por: Deben, Christophe, et al.
Publicado: (2015)

Nutlin-3a Decreases Male Fertility via UQCRC2
por: Shukla, Kamla Kant, et al.
Publicado: (2013)

New hope for Nutlin-3a therapy for pulmonary arterial hypertension
por: Fukumoto, Jutaro, et al.
Publicado: (2013)

Nutlin‐3a selects for cells harbouring TP 53 mutations
por: Kucab, Jill E., et al.
Publicado: (2016)

Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
por: Grillone, Agostina, et al.
Publicado: (2019)

Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin
por: Laroche, Audrey, et al.
Publicado: (2015)

MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia
por: Lerma Clavero, Ada, et al.
Publicado: (2023)

Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer
por: Zanjirband, Maryam, et al.
Publicado: (2016)

Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells ⋆
por: Pucci, Carlotta, et al.
Publicado: (2022)

Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells
por: Deben, Christophe, et al.
Publicado: (2021)

Modulation of anti-angiogenic activity using ultrasound-activated nutlin-loaded piezoelectric nanovectors
por: Şen, Özlem, et al.
Publicado: (2021)

Modulation of cisplatin cytotoxicity by sulphasalazine.
por: Awasthi, S., et al.
Publicado: (1994)

Oxidative stress-induced chromosome breaks within the ABL gene: a model for chromosome rearrangement in nasopharyngeal carcinoma
por: Tan, Sang-Nee, et al.
Publicado: (2018)

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
por: Gamble, Laura D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t3etg6571h11r6q7l4a1eojgih